Managed Entry Agreements and Funding for Expensive Therapies
Key reference to understand what's going on in this topic. Recommended.
Contents:
1. Introduction to Managed Entry Agreements
2. Definition and Classification of MEAs
3. From Coverage with Evidence Development to Individual Performance-Based Agreements in Italy
4. Coverage with Evidence Development for Multiple Sclerosis Drugs in the UK: A "Costly Failure"?
5. Country Comparison of the Implementation of Managed Entry Agreements
6. Novel Funding Models for Expensive Therapies
7. Managed Entry Agreement for Cell and Gene Therapies
